These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28847252)

  • 21. Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
    Henry DW; Marshall JL; Nazzaro D; Fox JL; Leff RD
    Am J Health Syst Pharm; 1995 Nov; 52(22):2570-3. PubMed ID: 8590244
    [No Abstract]   [Full Text] [Related]  

  • 22. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of ondansetron and prochlorperazine for the prevention of nausea and vomiting after tympanoplasty.
    van den Berg AA
    Can J Anaesth; 1996 Sep; 43(9):939-45. PubMed ID: 8874912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ondansetron hydrochloride injection and tablet against nausea and vomiting in lung cancer patients receiving carboplatin].
    Miyamoto Y; Yagi K; Teramachi M; Oomasa M; Tomiyama K
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):125-30. PubMed ID: 9987508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ondansetron for the prevention of vomiting after laparoscopic cholecystectomy].
    Figueredo E; Muñoz Blanco F
    Rev Esp Anestesiol Reanim; 1998; 45(6):258-9. PubMed ID: 9719729
    [No Abstract]   [Full Text] [Related]  

  • 26. Ondansetron oral dissolving tablets are superior to normal saline alone for prehospital nausea.
    Fullerton L; Weiss SJ; Froman P; Oglesbee S; Cheney P
    Prehosp Emerg Care; 2012; 16(4):463-8. PubMed ID: 22742574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting.
    Bosnjak SM; Neskovic-Konstantinovic ZB; Jovanovic-Micic DJ; Mitrovic LB; Radulovic SS
    J Chemother; 1996 Aug; 8(4):315-8. PubMed ID: 8873840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit.
    Ng WL; Della-Fiorentina SA
    Eur J Cancer Care (Engl); 2010 May; 19(3):403-7. PubMed ID: 19686353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3°C.
    Simar J; Godet M; Hecq JD; Closset M; Gillet P; Langhendries C; Bihin B; Jamart J; Galanti L
    Ann Pharm Fr; 2017 Jan; 75(1):30-39. PubMed ID: 27634586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of postoperative nausea and vomiting with ondansetron: a prospective, randomized, double-blind study in 90 patients].
    Polati E; Finco G; Bartoloni A; Gottin L; Pinaroli AM; Zanoni L; Mazzetti C; Fontanive P
    Minerva Anestesiol; 1995 Sep; 61(9):373-9. PubMed ID: 8919833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.
    Marty M
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S41-5. PubMed ID: 2533898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the administration time of ondansetron, a preventive for postoperative nausea and vomiting: prospective, randomized, double-blind study in 120 patients].
    Ploner F; Kainzwaldner A
    Anaesthesist; 1997 Jul; 46(7):583-7. PubMed ID: 9304358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation.
    Spitzer TR; Bryson JC; Cirenza E; Foelber R; Wallerstadt M; Stout C; Kunka RL; Plagge PB; Dubois A
    J Clin Oncol; 1994 Nov; 12(11):2432-8. PubMed ID: 7964960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases.
    Josefson A; Kreuter M
    Rheumatology (Oxford); 2003 Oct; 42(10):1149-54. PubMed ID: 12777644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral ondansetron: a useful addition to the supportive care armamentarium?
    Hesketh PJ
    Am J Clin Oncol; 1994 Apr; 17(2):147-9. PubMed ID: 8141106
    [No Abstract]   [Full Text] [Related]  

  • 36. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances.
    Fernández-Peña A; Katsumiti A; De Basagoiti A; Castaño M; Ros G; Sautua S; De Miguel M; Campino A
    Eur J Pediatr; 2021 Jul; 180(7):2305-2313. PubMed ID: 33738517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of binary, ternary and quaternary mixtures for induction and maintenance of opioid free anesthesia.
    Tauste-Hernández B; Cortiñas-Sáenz M; Fernández-Ginés FD; Expósito-López JM
    Farm Hosp; 2021 Apr; 45(3):135-141. PubMed ID: 33941057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.
    Estan-Cerezo G; Matoses-Chirivella C; Soriano-Irigaray L; Murcia-López AC; Rodríguez-Lucena FJ; Navarro-Ruiz A
    Eur J Hosp Pharm; 2018 Jul; 25(4):200-203. PubMed ID: 31157019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.